Kimberly-Clark (NASDAQ:KMB) reports Q3 2026 in line with expectations

Kimberly-Clark reported Q3 2026 revenue of $4.13B, matching estimates, and adjusted EPS of $1.70, beating estimates by 3%. Operating margin declined to 12.5% from 15%, while free cash flow margin increased to 11.9% from 8.9%. Organic revenue fell 1.3% year on year.

Original reporting
Published Nov 5, 2026, 2:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 3:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kimberly-Clark (NASDAQ:KMB) reports Q3 2026 in line with expectations — source image
Decision brief

The 30-second read

$KMBNeutralMed
01

Why it matters

The earnings release provides fresh data on revenue, EPS, and margins, influencing short‑term price action.

02

Market read

Large‑cap earnings beat with margin pressure; traders may adjust positions based on the mixed signals.

03

What to watch

Potential upside from upcoming cost‑saving initiatives not disclosed in this release.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Kimberly-Clark is a leading consumer‑goods company with a diversified product portfolio.

Company-level read

Ticker impact

$KMBNeutralHigh confidence
Context

Kimberly-Clark reported Q3 2026 results with revenue in line, EPS beat expectations, and margin compression.

Expected impact

potential modest downside as investors digest lower operating margin despite EPS beat

Evidence & confidence

The beat is limited to EPS; operating margin fell sharply, suggesting cost pressures that could temper price gains.

Market effects

Consumer staples may see mixed sentiment as a major player reports margin compression.

U.S. consumer‑goods sector could face slight pressure.

Limited to investors tracking large‑cap earnings.

Counterpoint

Despite the EPS beat, the margin decline could signal deeper cost issues, making the stock a short candidate.

Key entities

  • Kimberly-Clark

    Consumer staples manufacturer reporting Q3 2026 results.

Related articles

$KMBMedAI 8/10

Kimberly-Clark’s Dividend Is Up 392% Since 1999. Can Its $49 Billion Deal Put That at Risk?

Kimberly-Clark (KMB) has increased its dividend by 392% since 1999, with a current quarterly payout of $1.28. The company's $49 billion acquisition of Kenvue, funded partly by debt, may test its dividend streak. In 2025, free cash flow was $1.64 billion, slightly below the $1.66 billion paid in dividends. Management aims for reduced leverage and cost synergies to support earnings and the dividend.

$KMBMedAI 8/10

Kimberly-Clark backs 2026 outlook despite China disruptions

Kimberly-Clark reported Q3 2026 net sales of $4.13B, down 0.4% YoY, with adjusted EPS up 17.2% to $1.70. China disruptions and North American inventory movements impacted sales. The company reaffirmed its 2026 outlook, expecting mid-single-digit adjusted operating profit growth and high single-digit adjusted EPS growth.

$KMBMed

Kimberly-Clark Corp (KMB) (Q3 2026) Earnings Call Highlights: Kenvue Deal Closes

Kimberly-Clark (KMB) CEO Mike Hsu and CFO Nelson Urdaneta discussed Q3 2026 earnings, Kenvue integration, and 2027 outlook. Hsu highlighted Kenvue's 3% organic growth and progress in brand performance. Urdaneta cited cost-mitigating actions and easier Q4 comparisons. They addressed North America's share performance, diaper market dynamics, and synergy plans, including $1.9B in cost savings. KMB maintained fiscal 2026 guidance despite challenges.